by McKesson Ventures | Jan 19, 2022 | Media Coverage, Portfolio News
RxVantage recently shared news of its latest investment directed by McKesson Ventures and Spectrum Equity. These two investors will be joining RxVantage’s existing investors, which include Merck Global Health Innovation Fund, Slater Technology Fund, Javelin Venture...
by McKesson Ventures | Jul 23, 2021 | Media Coverage
While there are more startups than ever, there’s also more money chasing them than ever. Vator News is profiling key members of the investment community to help companies understand what investors are looking for and how they can help startups to scale. In this...
by McKesson Ventures | Jul 12, 2021 | Media Coverage
In a recent episode of the Virtual Care Paradigm, McKesson Ventures Partner Michelle Snyder discussed how a virtual-first approach to healthcare could become the new norm. Snyder started off by discussing the growing interest in investing in primary care. “I remember...
by McKesson Ventures | Jun 28, 2021 | Media Coverage
McKesson Ventures Partner Michelle Snyder was one of the speakers at a recent HLTH webinar on investment trends in the health tech field. The webinar, held June 24, 2021, also featured Keith Figloli, general partner at LVRHealth; and Anne Wellington, managing director...
by McKesson Ventures | May 10, 2021 | Media Coverage
US Oncology Research, supported by McKesson and the US Oncology Network, has a network of experienced and dedicated clinical staff and investigators who specialize in Phase I through Phase IV clinical trials. Robert Coleman, MD, FACOG, FACS, serves as its Chief...
by McKesson Ventures | Apr 30, 2021 | Media Coverage
Alula, McKesson’s first digital cancer treatment marketplace partner, opened up its DTC marketplace in April. The purpose? Make it easier for cancer patients to find and purchase the products they need at any given stage of their treatment. Liya Shuster-Bier was a...
